Ovary

Germ cell tumors

Monodermal teratomas

Carcinoid tumor



Last author update: 23 May 2024
Last staff update: 23 May 2024

Copyright: 2003-2024, PathologyOutlines.com, Inc.

PubMed Search: Ovarian carcinoid tumor

Ekaterina Menshikova, M.D.
Krisztina Hanley, M.D.
Cite this page: Menshikova E, Hanley K. Carcinoid tumor. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/ovarytumorcarcinoid.html. Accessed December 22nd, 2024.
Definition / general
  • Primary ovarian carcinoid tumors are well differentiated neuroendocrine tumors resembling those arising in the gastrointestinal tract
  • In some cases, teratomatous components are identified (component of mature cystic teratoma)
  • 4 types: insular, trabecular, strumal and mucinous
Essential features
  • Unilateral
  • May be associated with carcinoid syndrome
  • Rare
Terminology
  • Classified as monodermal teratomas
ICD coding
  • ICD-O: 9091/1 - strumal carcinoid
  • ICD-10
    • C56 - malignant neoplasm of ovary
    • C56.9 - malignant neoplasm of unspecified ovary
    • C7A.09 - malignant carcinoid tumors of other sites
    • D3A.09 - benign carcinoid tumors of other sites
  • ICD-11: 2F76 & XH2XW3 - neoplasms of uncertain behavior of female genital organs & strumal carcinoid
Epidemiology
  • Primary ovarian carcinoid is rare and accounts for
  • Patient age at time of presentation ranges from 17 to 83 years with a median of 55 (Gynecol Oncol 1996;61:259)
    • Mucinous: observed in a younger group of patients compared to other ovarian carcinoids
  • Insular type is the most common (~50%); mucinous is the least common
Sites
  • Ovary (Curr Opin Obstet Gynecol 1997;9:44)
    • Primary ovarian carcinoids are unilateral
    • Metastatic nearly always bilateral
  • Most arise in mature cystic teratoma or in association with mucinous tumor
  • Pure form is less frequent; may be associated with struma ovarii
Pathophysiology
  • Pathogenesis remains unclear
Etiology
  • Arises from neuroendocrine cells within gastrointestinal type epithelium of mature cystic teratoma or rarely other tumors
Clinical features
  • Asymptomatic, incidental finding
  • Abdominal mass
  • Ascites
  • Carcinoid syndrome
    • ~33% of patients are > 50 years old
    • Presence of carcinoid syndrome correlates with size of the tumor; typically seen in tumors > 7 cm, rarely seen in tumors < 4 cm
    • Most common in insular type
    • Does not require the presence of liver metastasis since venous drainage bypasses portal venous circulation (Tex Heart Inst J 2019;46:21)
    • Carcinoid heart disease may be the initial manifestation
      • Occurs in < 10% of cases of primary ovarian carcinoid
      • Generally involves right chambers and valves
  • Endocrine effects thought to occur due to stromal luteinization (Diagnostics (Basel) 2022;12:2706)
    • Virilization
    • Hirsutism
    • Endometrial hyperplasia
    • Cushing syndrome
  • Constipation due to inhibitory effect on gastrointestinal motility of peptide YY secreted in strumal carcinoid (Obstet Gynecol Sci 2017;60:602)
  • Hyperthyroidism in strumal carcinoid
Diagnosis
  • Preoperative diagnosis of primary ovarian carcinoid is challenging; typically, the mass is properly classified postoperatively
  • May be detected as a mass on physical examination
  • Imaging: ovarian mass lacks typical imaging characteristics
  • Somatostatin receptor scintigraphy: useful in detection of neuroendocrine tumors that show intensive octreotide intake (Am J Case Rep 2022;23:e937403)
  • Cytologic features: polygonal uniform cells, round monotonous nuclei, salt and pepper chromatin, ample to eosinophilic cytoplasm, often containing red to brown argentaffin granules; low mitotic activity
  • Mucinous carcinoids cytologically show cells exhibiting neuroendocrine and mucinous differentiation; signet ring cells may be seen in the stroma
  • WHO essential and desirable diagnostic criteria
    • Essential
      • Insular architecture (if insular carcinoid)
      • Trabecular or corded architecture (if trabecular carcinoid)
      • Thyroid follicles intimately admixed or juxtaposed with carcinoid (if strumal carcinoid)
      • Acini or glands with goblet cells free floating in mucin (if mucinous carcinoid)
      • Salt and pepper chromatin pattern of the nuclei, with or without cytoplasmic granules
    • Desirable: positivity for neuroendocrine markers
Laboratory
  • Tumor markers may be elevated (Acta Obstet Gynecol Scand 2023;102:935)
    • Elevation of CA125 and CA19-9 may mimic ovarian carcinoma
    • Neuron specific enolase (NSE)
    • Carcinoembryonic antigen (CEA)
  • Tumor markers used in carcinoid syndrome to monitor disease activity, response to therapy and early detection of metastasis (Endocrinol Metab Clin North Am 2017;46:669)
    • 5-hydroxyindole acetic acid (5-HIAA)
    • Chromogranin A
Radiology description
  • Ultrasound
  • Computed tomography (CT)
    • Unilateral, lobulated adnexal mass with scattered necrotic areas indistinguishable from other solid ovarian neoplasms
    • Solid enhancing nodule in the wall of a mature cystic teratoma or a mucinous neoplasm
  • Magnetic resonance imaging (MRI)
    • On T2 weighted MR images, hypointense solid adnexal mass or low intensity focus within a multilocular cystic mass
Radiology images

Contributed by Chenxi Wu, M.D., Ph.D.
T1 precontast MRI

T1 precontast MRI

T2 MRI

T2 MRI

Noncontrast CT, coronal plane

Noncontrast CT, coronal plane

Prognostic factors
  • 5 year survival rate of ovarian carcinoid is 84% and 94% in patients with and without mature cystic teratoma, respectively
  • Insular carcinoid
    • Favorable prognosis
    • Slow growing
    • Only occasionally has metastasis
  • Trabecular carcinoid
    • Favorable prognosis
    • Not associated with metastasis
  • Strumal carcinoid
  • Mucinous
    • Behaves more aggressively than other types of primary ovarian carcinoid
    • Tends to spread mainly via lymphatics and can metastasize
    • No metastases, better prognosis
  • Low Ki67 proliferative index; mean index of 2.5% with a maximum of 5% (Acta Obstet Gynecol Scand 2023;102:935)
  • Carcinoid heart syndrome has been reported to be associated with overall poor outcome
Case reports
Treatment
  • Treatment strategies vary (Acta Obstet Gynecol Scand 2023;102:935)
  • Surgical
    • Conservative
      • Cystectomy
      • Unilateral salpingo-oophorectomy, especially in reproductive age women
    • Radical surgery
      • Bilateral salpingo-oophorectomy
      • Hysterectomy and bilateral salpingo-oophorectomy
      • In mucinous carcinoid, regional lymph node dissection may be required
    • Cytoreductive surgery
  • Adjuvant treatment restricted to patients with residual or metastatic diseases
  • Somatostatin analogs: may be used in metastatic or recurrent primary ovarian carcinoids; treatment of symptoms of excess hormone secretion and for tumor growth control
Clinical images

Images hosted on other servers:

Ovarian mass intraoperatively

Gross description
  • Usually present as firm, solid and homogeneous gray to yellow masses in association with mature teratoma or mucinous tumor (Curr Opin Obstet Gynecol 1997;9:44)
  • If pure (Curr Opin Obstet Gynecol 1997;9:44)
    • Strumal carcinoid: solid yellow-brown nodule with fleshy areas
    • Mucinous carcinoid: gray-yellow, firm, usually solid but may contain cystic areas even when seen in a pure form; most tumors > 8 cm
Gross images

AFIP images
Missing Image

Insular tumor

Microscopic (histologic) description
  • 4 types (J Int Med Res 2021;49:3000605211034666)
    • Insular carcinoid
      • Most common type of ovarian carcinoid
      • Growth pattern usually shows large islands, variable sized nests, small acini or glands within the fibrous stroma
        • Simple tubular glands, cribriform nests may also be seen
        • Retraction artifact around tumor cells is common
      • Composed of uniform polygonal epithelial cells with abundant cytoplasm and round, centrally located nuclei; cytoplasm contains red-brown granules, located basally
      • Secretions in lumina, psammoma bodies
      • Stroma is dense and hyalinized
      • Low mitotic activity
    • Trabecular carcinoid
      • Associated with mature cystic teratoma, rare in pure form
      • 1 or 2 cell layers arranged in long, wavy, branching cords, parallel ribbons or trabeculae
      • Occasionally, acinar pattern may be seen admixed with trabecular pattern
      • Tumor cells are uniform, round to oval, with amphophilic, slightly granular cytoplasm at the base and prominent, centrally located, ovoid or elongated nuclei with finely stippled chromatin; red-brown granules may be seen at the cell base
      • Stroma is represented by dense fibrous connective tissue, which may be hyalinized or luteinized
      • Low mitotic activity, only occasional mitoses
    • Strumal carcinoid
      • Commonly associated with mature cystic teratoma; often is seen in pure form (40%); rarely can be associated with mucinous tumor (J Cancer Res Clin Oncol 1984;107:125, J Int Med Res 2021;49:3000605211034666, Front Endocrinol (Lausanne) 2022;13:871210)
      • Composed of thyroid tissue intimately admixed or juxtaposed with a neuroendocrine neoplasm (struma ovarii and carcinoid)
      • Either of the components may be predominant
        • Trabecular pattern >> both trabecular and insular patterns > insular only
        • Thyroid component resembles normal thyroid tissue; rarely, papillary or follicular carcinoma may be present
      • Stroma may show luteinization
    • Mucinous carcinoid
      • These morphologically resemble low grade goblet cell adenocarcinoma of the appendix (previously termed goblet cell carcinoid)
      • Pure form >> in association with mature cystic teratoma
      • Composed of numerous small glands or acini with very small lumina floating in pools of mucin (pseudomyoxoma ovarii); some of the glands or acini may be cystically dilated containing mucin
      • Lined by uniform cuboid or columnar and goblet cells and containing small round or oval nuclei and cytoplasmic neuroendocrine granules
      • In some areas, the tumor cells tend to invade the surrounding connective tissue, often assuming signet ring appearance
      • Tumor may form large solid aggregates, show a less uniform appearance and have more atypical features with large hyperchromatic nuclei and brisk mitotic activity
  • Can also be mixed and present as a combination of 2 or more types of carcinoids
Microscopic (histologic) images

Contributed by Krisztina Hanley, M.D., Rulong Shen, M.D. and AFIP
Trabecular pattern

Trabecular pattern

Nuclear features

Nuclear features

Mixed patterns

Mixed patterns

Strumal carcinoid Strumal carcinoid

Strumal carcinoid

Thyroid component

Thyroid component


Cytologic features of carcinoid

Cytologic features of carcinoid

Chromogranin in strumal ovarian carcinoid

Chromogranin in strumal ovarian carcinoid

Synaptophysin in strumal ovarian carcinoid

Synaptophysin in strumal ovarian carcinoid

Insular carcinoid Missing Image

Insular carcinoid

Missing Image

Insular carcinoid


Missing Image Missing Image

Insular carcinoid

Missing Image

TTF1

Missing Image

AE1 / AE3

Missing Image

CDX2

Missing Image

Synaptophysin


Missing Image

Chromogranin

Missing Image

Inhibin

Missing Image Missing Image

Mucinous carcinoid

Trabecular tumor

Virtual slides

Images hosted on other servers:
Carcinoid and mature cystic teratoma

Carcinoid and mature cystic teratoma

Positive stains
Negative stains
Electron microscopy description
  • Numerous neurosecretory granules
Videos

Germ cell neoplasms of the ovary - ovarian carcinoid tumor
by Dr. Wafaey Badawy

Sample pathology report
  • Right ovary, oophorectomy:
    • Ovarian carcinoid tumor, arising from struma ovarii (see comment)
    • Comment: Sections show extensive involvement of the ovary by a well differentiated neuroendocrine tumor, showing acinar, trabecular, tubular, corded and some rare areas of solid growth patterns, confined to the ovary without surface involvement. Background shows benign thyroid tissue. Immunohistochemical stains including chromogranin and synaptophysin support neuroendocrine differentiation. Given the presence of benign thyroid tissue, this neoplasm is classified as a strumal carcinoid. The use of proliferative markers such as Ki67 has not been established in the grading of these tumors and in this case, it is < 1%

  • Left ovarian cyst, resection:
    • Ovarian carcinoid tumor (4.5 mm), trabecular type, arising in a mature cystic teratoma (dermoid cyst) (see comment)
    • Comment: Extensive sampling of this mature teratoma shows a 4.5 mm trabecular carcinoid tumor. Immunohistochemical stains confirm neuroendocrine differentiation as the tumor cells are positive for synaptophysin, chromogranin, CD56, MCK (AE1 / AE3) and Ki67 is ~2%. This small focus of carcinoid tumor shows CDX2 positivity indicating midgut origin, similar to the gastrointestinal counterpart.
Differential diagnosis
  • Carcinoid metastasis:
    • Bilateral, no associated teratoma or struma ovarii
    • Often multinodular growth
    • Microscopically indistinguishable from primary
    • Most commonly from midgut primary
  • Brenner tumor:
    • May be confused with insular carcinoid
    • Transitional epithelial cells, grooved nuclei, lack of cytoplasmic granules
  • Krukenberg tumor:
    • Bilateral, marked cellular and nuclear pleomorphism
    • Mitotically active, abundant mucin
    • Signet ring cells are common
    • Lymphovascular invasion is common
  • Sertoli cell tumor (SCT) with trabecular architecture:
Board review style question #1

Which of the following is true for primary ovarian carcinoid?

  1. Most cases of primary ovarian carcinoid are associated with mature cystic teratoma
  2. Mucinous ovarian carcinoid behaves less aggressively than other types
  3. Primary ovarian carcinoids are poorly differentiated neuroendocrine tumors
  4. To cause carcinoid syndrome, the presence of liver metastasis is required
Board review style answer #1
A. Most cases of primary ovarian carcinoid are associated with mature cystic teratoma. Despite mucinous ovarian carcinoids more frequently occurring in pure form, 3 of 4 types, including the most common insular type, mostly arise in mature cystic teratoma. Answer B is incorrect because mucinous ovarian carcinoid is more aggressive than other types of primary ovarian carcinoid. Answer C is incorrect because per definition, primary ovarian carcinoid tumors are well differentiated neuroendocrine tumors. Answer D is incorrect because ovarian veins drain directly into systemic circulation: the right ovarian vein drains directly into the inferior vena cava, while the left ovarian vein joins the left renal vein. Therefore, hormones produced by a carcinoid tumor do not undergo hepatic metabolism.

Comment Here

Reference: Carcinoid tumor
Board review style question #2
Which of the following indicates poor prognosis of patients with primary ovarian carcinoid?

  1. Carcinoid heart syndrome
  2. Insular type
  3. Low Ki67 proliferative index
  4. Trabecular type
  5. Tumor confined to the ovary
Board review style answer #2
A. Carcinoid heart syndrome can be a presenting symptom even in the absence of liver metastases. The 3 year survival has been reported to be 31%. Answer B is incorrect because insular type is slow growing and only occasionally metastasizes. The prognosis is favorable. Answer C is incorrect because a high Ki67 proliferative index, not low, is associated with worse outcomes. Answer D is incorrect because trabecular type is not associated with metastasis and has favorable prognosis. Answer E is incorrect because the absence of tumor spread is a good prognostic factor.

Comment Here

Reference: Carcinoid tumor
Back to top
Image 01 Image 02